Statement: Senate Health Leader’s Drug Pricing Transparency Bill Clears a Crucial Committee

September 1, 2017

SB 17 passed Assembly Appropriations Committee, now heads to the Assembly Floor

SACRAMENTOSenator Dr. Ed Hernandez, O.D., chair of the Senate Health Committee, issued the following statement on the Assembly Appropriations Committee’s approval of Senate Bill 17 – shining a light on drug prices:

“Californians expect their government to do more to control health care costs, and drug companies shouldn’t be immune from this effort. Big Pharma continues to operate in the shadows, raising drug prices without any advanced notice or justification. We deserve better. SB 17 is a positive step forward to bring sunshine and transparency to Big Pharma’s practices. I thank Assembly Appropriations Committee Chair Lorena Gonzalez Fletcher for her support and moving the measure forward. I look forward to its approval before the entire Assembly.”

See the diverse SB 17 support coalition of consumer, patient, business, labor, and health care groups.